Sobi Acquires Arthrosi Therapeutics To Enhance Gout Treatment
09 Feb 2026 //
PR NEWSWIRE BIO
Sobi to buy US Biotech Arthrosi for up to $1.5 B
13 Dec 2025 //
REUTERS
Arthrosi Raises $153M, Fueling Dash Toward Phase 3 Gout Data
08 Oct 2025 //
FIERCE BIOTECH
Arthrosi Completes Ph3 Trial Enrollment for Pozdeutinurad in Gout
20 Aug 2025 //
PR NEWSWIRE

Market Place
Sourcing Support